DSM-IV: 309.81 - Posttraumatic Stress Disorder F43.1
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Sexual or physical abuse after the age of three (definition according to the American Psychological Association Committee on Professional Practice and Standards, 1999) PTSD (according to CAPS-CA: meeting 1 B-criterion, 2 C-criteria, 2 D-criteria) persisting for longer than one month PTSD as primary diagnosis Living in safe conditions Sufficient knowledge of German language Informed consent from parents/legal guardians (if under 18) and participant Stable psychopharmacological medication at study entry (in the last 3 weeks there was either no or a constant psychopharmacological medication)
Exclusion criteria
Exclusion criteria: Acute suicidality within the last 6 months Life threatening self-harming behavior within the last 6 months Substance related or organic mental disorder Pervasive developmental disorder Current or lifetime diagnosis of a psychotic disorder according to DSM-IV Current or lifetime diagnosis of a bipolar disorder according to DSM-IV Current diagnosis of substance dependence according to DSM-IV (abstinence < 6 months) Mental retardation (IQ = 75) Simultaneous psychotherapeutic treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of PTSD Measure: German version of the Clinician Administered PTSD Scale for Children and Adolescents (CAPS-CA, in German IBS-P-KJ; Steil & Füchsel, 2006) Measurement points: Pretest (before starting the treatment), Posttest (after ending the treatment, approx. 16 weeks), Follow-Up I (3 months after ending the treatment), Follow-Up II (6 months after ending the treatment; for patients of the TAU-arm only those, who didn’t choose D-CPT after Follow-Up I) | — |
Secondary
| Measure | Time frame |
|---|---|
| Each at Pretest (before starting the treatment), Posttest (after ending the treatment, approx. 16 weeks), Follow-Up I (3 months after ending the treatment), Follow-Up II (6 months after ending the treatment; for patients of the TAU-arm only those, who didn’t choose D-CPT after Follow-Up I): 1.Self-rating of PTSD symptoms : German version of the UCLA PTSD INDEX for DSM IV (Arbeitsgruppe Psychotraumatologie KJP Ulm, 2008), German version of the Trauma Symptom Checklist for Children (Matulis & Steil, 2010) 2.Axis I and II comorbidity: German version of the Structured Clinical Interview for DSM Disorders (SKID; Wittchen, Zaudig & Fydrich, 1997), further important parts of the Diagnostic Interview for Mental Disorders in Childhood and Adolescence (Kinder-DIPS; Schneider, Unnewehr & Margraf, 2009), nicotine section of the Expert System for Diagnosing Mental Disorders (DIA-X, Wittchen & Pfister, 1997) 3.Depressive symptoms: German version of the Beck Depression Inventory (BDI-II; Hautzinger, Keller & Kühner, 2006) 4.Dissociative symptoms: German version of the adolescent Dissociative Experiences Scale (HDI; Brunner, Resch, Parzer & Koch, 2008) 5.Symptoms of emotional disregulation: German version of the Borderline Symptom Checklist 23 (BSL-23; Bohus, Kleindienst, Limberger, Stieglitz, Domsalla, Chapman et al., 2009) 6.General pathology and impairment: German version of the Youth-Self-Report (YSR; Döpfner, 1998) 7.Service use and quality of life: Client Sociodemographic and Service Receipt Inventory (CSSRI; Chisholm et al., 2000), EuroQol 5 Dimensions (EQ-5D; Dolan, 1997) Each at Pretest (before starting the treatment) and Follow-Up I (3 months after ending the treatment): 1.Assessment of psychophysiological parameters by Electroencephalogram (EEG) 2.Epigenetic micro-array analyses of DNA saliva samples | — |
Countries
Germany
Contacts
Katholische Universität Eichstätt-Ingolstadt; Lehrstuhl Klinische und Biologische Psychologie